Are you Dr. Lowe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2230 NW Pettygrove St
Ste 210
Portland, OR 97210Phone+1 503-223-6223Fax+1 503-223-3665
Summary
- Dr. Bruce Lowe, MD is a board certified urologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Minnesota, and New Mexico.
Education & Training
Vanderbilt University Medical CenterResidency, Urology, 1978 - 1982- Vanderbilt University Medical CenterResidency, Surgery, 1976 - 1978
University of Kansas School of MedicineClass of 1976
Certifications & Licensure
OR State Medical License 1988 - 2024
MN State Medical License 2019 - 2023
NM State Medical License 1982 - 1992
TN State Medical License 1977 - 1992- American Board of Urology Urology
Awards, Honors, & Recognition
- Portland Monthly Magazine Castle Connolly, 2011
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 38 citationsTen-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: Update on southwest...Ryan K. Berglund, Catherine M. Tangen, Isaac J. Powell, Bruce A. Lowe, Gabriel P. Haas
Urology. 2012-03-01 - 696 citationsA randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooper...Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson, E D Crawford, P Kuebler
Journal of Clinical Oncology. 1992-07-01 - 662 citationsBilateral orchiectomy with or without flutamide for metastatic prostate cancerMario A. Eisenberger, Brent A. Blumenstein, E. David Crawford, Gary J. Miller, David G. McLeod
The New England Journal of Medicine. 1998-10-08
Grant Support
- Bropipimine In Patients With Superficial Bladder CancerNational Center For Research Resources1992–1994
